Bronchoalveolar lavage fluid sample pretreatment with Sputasol(®) significantly reduces galactomannan levels

J Infect. 2015 May;70(5):541-3. doi: 10.1016/j.jinf.2014.11.005. Epub 2014 Nov 18.

¹ Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria. Electronic address: [email protected].
² Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Universitätsplatz 4, 8010 Graz, Austria.
³ Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria; Division of Pulmonology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
⁴ Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
⁵ Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria; Division of Pulmonology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria; Division of Infectious Diseases, University of California San Diego (UCSD), 220 Dickinson Street, San Diego, CA 92103, United States.

No abstract available

Keywords: Aspergillus; Bronchoalveolar lavage fluid; Dithiothreitol; Galactomannan; Lateral flow device test; Sputasol.

Publication types